Cargando…
Genomics of diffuse large B cell lymphoma
Next generation sequencing (NGS) technology has revealed the heterogeneity of diffuse large B-cell lymphoma (DLBCL) from a mutation perspective. Accordingly, the conventional cell of origin-based classification of DLBCL has changed to a mutation-based classification. Mutation analysis delineates tha...
Autor principal: | Koh, Youngil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094001/ https://www.ncbi.nlm.nih.gov/pubmed/33935039 http://dx.doi.org/10.5045/br.2021.2021049 |
Ejemplares similares
-
Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma
por: Kim, Dae Wook, et al.
Publicado: (2023) -
Diffuse Large B-Cell Lymphoma’s New Genomics: The Bridge and the Chasm
por: Crombie, Jennifer L., et al.
Publicado: (2020) -
Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012) -
Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012) -
Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)